IBDEI2S2 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46629,2)
 ;;=^5011757
 ;;^UTILITY(U,$J,358.3,46630,0)
 ;;=J67.9^^206^2305^12
 ;;^UTILITY(U,$J,358.3,46630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46630,1,3,0)
 ;;=3^Hypersensitivity Pneumonitis d/t Unspec Organic Dust
 ;;^UTILITY(U,$J,358.3,46630,1,4,0)
 ;;=4^J67.9
 ;;^UTILITY(U,$J,358.3,46630,2)
 ;;=^5008280
 ;;^UTILITY(U,$J,358.3,46631,0)
 ;;=J84.17^^206^2305^14
 ;;^UTILITY(U,$J,358.3,46631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46631,1,3,0)
 ;;=3^Idiopathic Interstitial Pneumonia in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,46631,1,4,0)
 ;;=4^J84.17
 ;;^UTILITY(U,$J,358.3,46631,2)
 ;;=^5008301
 ;;^UTILITY(U,$J,358.3,46632,0)
 ;;=J84.113^^206^2305^15
 ;;^UTILITY(U,$J,358.3,46632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46632,1,3,0)
 ;;=3^Idiopathic Non-Specific Interstitial Pneumonitis
 ;;^UTILITY(U,$J,358.3,46632,1,4,0)
 ;;=4^J84.113
 ;;^UTILITY(U,$J,358.3,46632,2)
 ;;=^340535
 ;;^UTILITY(U,$J,358.3,46633,0)
 ;;=J84.112^^206^2305^16
 ;;^UTILITY(U,$J,358.3,46633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46633,1,3,0)
 ;;=3^Idiopathic Pulmonary Fibrosis
 ;;^UTILITY(U,$J,358.3,46633,1,4,0)
 ;;=4^J84.112
 ;;^UTILITY(U,$J,358.3,46633,2)
 ;;=^340534
 ;;^UTILITY(U,$J,358.3,46634,0)
 ;;=J84.111^^206^2305^13
 ;;^UTILITY(U,$J,358.3,46634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46634,1,3,0)
 ;;=3^Idiopathic Interstitial Pneumonia NOS
 ;;^UTILITY(U,$J,358.3,46634,1,4,0)
 ;;=4^J84.111
 ;;^UTILITY(U,$J,358.3,46634,2)
 ;;=^340610
 ;;^UTILITY(U,$J,358.3,46635,0)
 ;;=J84.9^^206^2305^17
 ;;^UTILITY(U,$J,358.3,46635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46635,1,3,0)
 ;;=3^Interstitial Pulmonary Disease,Unspec
 ;;^UTILITY(U,$J,358.3,46635,1,4,0)
 ;;=4^J84.9
 ;;^UTILITY(U,$J,358.3,46635,2)
 ;;=^5008304
 ;;^UTILITY(U,$J,358.3,46636,0)
 ;;=M32.13^^206^2305^19
 ;;^UTILITY(U,$J,358.3,46636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46636,1,3,0)
 ;;=3^Lung Involvement in Systemic Lupus Erythematosus
 ;;^UTILITY(U,$J,358.3,46636,1,4,0)
 ;;=4^M32.13
 ;;^UTILITY(U,$J,358.3,46636,2)
 ;;=^5011756
 ;;^UTILITY(U,$J,358.3,46637,0)
 ;;=J84.2^^206^2305^20
 ;;^UTILITY(U,$J,358.3,46637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46637,1,3,0)
 ;;=3^Lymphoid Interstitial Pneumonia
 ;;^UTILITY(U,$J,358.3,46637,1,4,0)
 ;;=4^J84.2
 ;;^UTILITY(U,$J,358.3,46637,2)
 ;;=^5008302
 ;;^UTILITY(U,$J,358.3,46638,0)
 ;;=D86.82^^206^2305^21
 ;;^UTILITY(U,$J,358.3,46638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46638,1,3,0)
 ;;=3^Multiple Cranial Nerve Palsies in Sarcoidosis
 ;;^UTILITY(U,$J,358.3,46638,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,46638,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,46639,0)
 ;;=M32.8^^206^2305^60
 ;;^UTILITY(U,$J,358.3,46639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46639,1,3,0)
 ;;=3^Systemic Lupus Erythematosus NEC
 ;;^UTILITY(U,$J,358.3,46639,1,4,0)
 ;;=4^M32.8
 ;;^UTILITY(U,$J,358.3,46639,2)
 ;;=^5011760
 ;;^UTILITY(U,$J,358.3,46640,0)
 ;;=J84.17^^206^2305^18
 ;;^UTILITY(U,$J,358.3,46640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46640,1,3,0)
 ;;=3^Interstitial Pulmonary Diseases w/ Fibrosis
 ;;^UTILITY(U,$J,358.3,46640,1,4,0)
 ;;=4^J84.17
 ;;^UTILITY(U,$J,358.3,46640,2)
 ;;=^5008301
 ;;^UTILITY(U,$J,358.3,46641,0)
 ;;=J68.8^^206^2305^25
 ;;^UTILITY(U,$J,358.3,46641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46641,1,3,0)
 ;;=3^Respiratory Condition d/t Chemicals/Gases/Fumes/Vapors
 ;;^UTILITY(U,$J,358.3,46641,1,4,0)
 ;;=4^J68.8
 ;;^UTILITY(U,$J,358.3,46641,2)
 ;;=^5008286
 ;;^UTILITY(U,$J,358.3,46642,0)
 ;;=J69.0^^206^2305^22
 ;;^UTILITY(U,$J,358.3,46642,1,0)
 ;;=^358.31IA^4^2
